Elevated expression of NFE2L3 predicts the poor prognosis of pancreatic cancer patients
Authors:
- 2 September 2018
- journal article
- research article
- Published by Taylor & Francis in Cell Cycle
- Vol. 17 (17) , 2164-2174
Abstract
The highly malignant feature and difficulties for early diagnosis are the key reasons contributing to the poor prognosis of pancreatic cancer (PC) patients. NFE2L3 is a nuclear transcription factor, which has been reported an important biomarker of several tumors. But the role of NFE2L3 in PC remained undefined. Herein, through qPCR and immunohistochemistry, we found a significantly increased NFE2L3 in PC tissues as compared with adjacent non-tumor tissues. While reducing NFE2L3 expression suppressed the invasion abilities of PC cells, elevated NFE2L3 was found associated with lymph node metastasis (P = 0.001; HR = 3.95; 95% CI: 1.70 – 9.17) and advanced TNM stages (P < 0.001; HR = 4.06; 95% CI: 1.74 – 9.46). Consistently, data from both our two cohorts and the TCGA database revealed that higher NFE2L3 PC carriers had worse outcomes than those lower NFE2L3 expressers. Lastly, we confirmed the regulatory role of NFE2L3 on VEGFA, an important player involved in tumor angiogenesis. Collectively, our investigations suggested the oncogenic role of NFE2L3 in PC development and provided the rational for future adding NFE2L3 for the risk assessment of PC patients. Abbreviations: NFE2L3: NF-E2-related factor 3; UHMK1: U2AF homology motif kinase 1; VEGFA: vascular endothelial growth factor A; GEO: gene expression omnibus; TCGA: The Cancer Genome Atlas; HPDE: human pancreas duct cells; OS: overall survival; IHC: immunohistochemistry; FFPE: formalin-fixed and paraffin-embedded; SEM: standard error of meanKeywords
Funding Information
- Foundation of Shanghai Shen Kang Hospital Development Center (16CR2002A and 16CR3028A)
- National Science Foundation of China (81472240 and 81773184)
This publication has 29 references indexed in Scilit:
- Nfe2l3 (Nrf3) deficiency predisposes mice to T-cell lymphoblastic lymphomaBlood, 2011
- Nrf2: A central regulator of UV protection in the epidermisCell Cycle, 2010
- Crucial Role of Nrf3 in Smooth Muscle Cell Differentiation From Stem CellsCirculation Research, 2010
- Molecular biology of mantle cell lymphoma: From profiling studies to new therapeutic strategiesBlood Reviews, 2009
- Nrf2-induced antioxidant protection: A promising target to counteract ROS-mediated damage in neurodegenerative disease?Free Radical Biology and Medicine, 2008
- Genomic and gene expression signature of the pre-invasive testicular carcinoma in situCell and tissue research, 2005
- Complexity of CNC Transcription Factors As Revealed by Gene Targeting of the Nrf3 LocusMolecular and Cellular Biology, 2004
- Nrf2 Transcription Factor, a Novel Target of Keratinocyte Growth Factor Action Which Regulates Gene Expression and Inflammation in the Healing Skin WoundMolecular and Cellular Biology, 2002
- Gene Expression Omnibus: NCBI gene expression and hybridization array data repositoryNucleic Acids Research, 2002
- Molecules in focus The NF-E2 transcription factorThe International Journal of Biochemistry & Cell Biology, 1998